Erste Asset Management Gmb H Clovis Oncology, Inc. Transaction History

Erste Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 26, 2024	SELL	$0.63 - $2.96 $9,891 - $46,472	-15,700 Closed	0 $0
Q3 2019 Nov 22, 2024	SELL	$3.93 - $15.35 $61,701 - $240,995	-15,700 Closed	0 $0
Q1 2019 Nov 22, 2024	BUY	$17.66 - $30.28 $277,262 - $475,396	15,700 New	15,700 $382 Million
Q4 2018 Nov 26, 2024	BUY	$11.63 - $32.67 $182,591 - $512,919	15,700 New	15,700 $282 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.